Seer core infrastructure support, base period

Active Awarded Last action

Contract number
75N91021F00001
Awardee
Awarding agency
Obligated
$7,526,901

Award facts

Opportunity
Contract value 83% obligated
  • $7,752,964.00 Current, with exercised options
  • $9,085,109.00 Potential, with all options
Completion date 79% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
New Brunswick, NJ 08903, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 $292,756
Exercise an Option P00008 $950,229
Exercise an Option P00007 $1,124,500
Funding Only Action P00006 $210,389
Exercise an Option P00005 $1,051,948
Exercise an Option P00004 $1,239,985
Exercise an Option P00003 $1,218,072
Funding Only Action P00002 · Seer core infrastructure support $99,611
Exercise an Option P00001 $1,095,720
Original award $243,691

About this award

The National Cancer Institute issued a delivery order to Rutgers The State University of New Jersey on March 3, 2021, under the Surveillance Epidemiology and End Results (SEER) parent vehicle, with a ceiling value of $9,085,109 and an ultimate completion date of April 30, 2028. The order is priced on a cost-no-fee basis and supports SEER core infrastructure operations.

Place of performance is New Brunswick, New Jersey. The order requires surveillance epidemiology and end results program infrastructure support across the base performance period.

Service Contract Inventory reporting reflects actual government-invoiced labor activity. FY2024 invoicing totaled $1.3 million across 9.2 FTEs and 19,105 contractor hours, with no subcontractors reported—the awardee self-performed all work. The derived government-paid hourly rate has declined from $95.62/hr in FY2021 to $68.34/hr in FY2024, reflecting a downward pricing trend across the award's performance to date. FY2021 through FY2023 showed year-over-year growth in labor footprint and invoiced revenue, with FY2024 invoicing holding steady against FY2023 despite increased FTE deployment.

Quick answers

Who was awarded contract 75N91021F00001?

75N91021F00001 was awarded to Rutgers The State University Of New Jersey by National Cancer Institute (National Institutes of Health) on March 3, 2021.

How much is contract 75N91021F00001 worth?

The government has obligated $7,526,901 on 75N91021F00001. Its current value, with exercised options, is $7,752,964. Its potential value, with all options, is $9,085,109.

Is contract 75N91021F00001 an order under another contract?

Yes. 75N91021F00001 is a delivery order under 75N91021D00009, an indefinite delivery contract, on Surveillance Epidemiology and End Results (SEER).

Was contract 75N91021F00001 competed?

The extent of competition for 75N91021F00001 was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award